Access Bio Inc (950130) — Capital Reinvestment Ratio
Latest as of March 2025:
0.12x
Access Bio Inc (950130) has a Capital Reinvestment Ratio of 0.12x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩5.35 Million) in capital expenditures (₩635.11K). See 950130 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.12x
Capex / Operating Cash Flow
Operating Cash Flow
₩5.35 Million
KRW
Capital Expenditures
₩635.11K
KRW
Data as of
Mar 2025
Most recent filing
Access Bio Inc Capital Reinvestment Ratio (2012–2024)
This chart tracks Access Bio Inc's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Access Bio Inc (2012–2024)
Year-by-year Capital Reinvestment Ratio for Access Bio Inc from 2012 to 2024. For live market cap and broader valuation context, see 950130 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | ₩13.54 Million | ₩1.40 Million | ▲ +101.5% |
| 2022 | 0.05x | ₩291.33 Million | ₩14.90 Million | ▼ -75.5% |
| 2021 | 0.21x | ₩137.90 Million | ₩28.76 Million | ▼ -26.3% |
| 2020 | 0.28x | ₩36.72 Billion | ₩10.38 Billion | ▼ -94.0% |
| 2016 | 4.74x | ₩2.11 Million | ₩10.03 Million | ▲ +180.1% |
| 2015 | 1.69x | ₩2.87 Billion | ₩4.85 Billion | ▲ +2.0% |
| 2013 | 1.66x | ₩1.59 Billion | ₩2.63 Billion | ▲ +134.3% |
| 2012 | 0.71x | ₩1.85 Billion | ₩1.31 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow